HRP20140583T1 - Formulacije koje sadrže ekstrakte echinacea angustifolia i zingiber officinale koje se koriste za smanjivanje upale i periferne boli - Google Patents
Formulacije koje sadrže ekstrakte echinacea angustifolia i zingiber officinale koje se koriste za smanjivanje upale i periferne boli Download PDFInfo
- Publication number
- HRP20140583T1 HRP20140583T1 HRP20140583AT HRP20140583T HRP20140583T1 HR P20140583 T1 HRP20140583 T1 HR P20140583T1 HR P20140583A T HRP20140583A T HR P20140583AT HR P20140583 T HRP20140583 T HR P20140583T HR P20140583 T1 HRP20140583 T1 HR P20140583T1
- Authority
- HR
- Croatia
- Prior art keywords
- combination
- zingiber officinale
- echinacea angustifolia
- pain
- extracts
- Prior art date
Links
- 244000133098 Echinacea angustifolia Species 0.000 title claims 5
- 244000273928 Zingiber officinale Species 0.000 title claims 5
- 235000006886 Zingiber officinale Nutrition 0.000 title claims 5
- 235000014134 echinacea Nutrition 0.000 title claims 5
- 239000000284 extract Substances 0.000 title claims 5
- 235000008397 ginger Nutrition 0.000 title claims 5
- 239000001841 zingiber officinale Substances 0.000 title claims 5
- 206010061218 Inflammation Diseases 0.000 title claims 3
- 230000004054 inflammatory process Effects 0.000 title claims 3
- 230000002093 peripheral effect Effects 0.000 title claims 3
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- KDSNLYIMUZNERS-UHFFFAOYSA-N 2-methylpropanamine Chemical class CC(C)CN KDSNLYIMUZNERS-UHFFFAOYSA-N 0.000 claims 2
- 208000035143 Bacterial infection Diseases 0.000 claims 2
- 206010017533 Fungal infection Diseases 0.000 claims 2
- 208000007101 Muscle Cramp Diseases 0.000 claims 2
- 208000031888 Mycoses Diseases 0.000 claims 2
- 206010030113 Oedema Diseases 0.000 claims 2
- 208000003251 Pruritus Diseases 0.000 claims 2
- 208000005392 Spasm Diseases 0.000 claims 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims 2
- 230000002538 fungal effect Effects 0.000 claims 2
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 claims 2
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 claims 2
- 235000002780 gingerol Nutrition 0.000 claims 2
- 230000000622 irritating effect Effects 0.000 claims 2
- 230000000771 oncological effect Effects 0.000 claims 2
- 208000006934 radiodermatitis Diseases 0.000 claims 2
- 238000001959 radiotherapy Methods 0.000 claims 2
- 208000007514 Herpes zoster Diseases 0.000 claims 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 claims 1
- 230000007803 itching Effects 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 150000003904 phospholipids Chemical class 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 238000003815 supercritical carbon dioxide extraction Methods 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (7)
1. Kombinacija lipofilnih ekstrakata Zingiber officinale i Echinacea angustifolia za upotrebu u liječenju svrbeži, periferne boli, površinskih ili dubokih upala i bolnih stanja, boli povezanih s mišićnim spazmama, boli urokovanih herpesom, radiodermatitisa induciranog onkološkom radioterapijom sa ili bez gljivičnih ili bakterijskih infekcija, edema ili iritativnih stanja kože uključujući one od pretjeranog izlaganja sunčevu svijetlu.
2. Kombinacija za upotrebu kao što je prijavljena u patentnom zahtjevu 1, naznačena time da su ekstrakti obaju vrsta dobiveni iz korijena ili rizoma ekstrakcijom superkritičnim ugljikovim dioksidom.
3. Kombinacija za upotrebu kao što je prijavljena u patentnim zahtjevima 1-2, naznačena time da sadrži izobutilamide iz Echinacea angustifolia i gingerol i Zingiber officinale u masenom omjeru raspona od 1:1 do 1:0.1.
4. Kombinacija za upotrebu kao što je prijavljena u patentnom zahtjevu 3, naznačena time da sadrži izobutilamide iz Echinacea angustifolia i gingerol i Zingiber officinale u masenom omjeru raspona od 1:1 do 1:0.5.
5. Pripravak koji sadrži kombinaciju lipofilnih ekstrakata Zingiber officinale i Echinacea angustifolia prema patentnim zahtjevima 1-4, zajedno s fiziološki kompatibilnim vezikulima i ekscipijensima, naznačen time da je za upotrebu u liječenju svrbeži, periferne boli, površinskih ili dubokih upala i bolnih stanja, boli povezanih s mišićnim spazmama, boli urokovanim herpesom, radiodermatitisa induciranog onkološkom radioterapijom sa ili bez gljivičnih ili bakterijskih infekcija, edema ili iritativnih stanja kože uključujući one od pretjeranog izlaganja sunčevu svijetlu.
6. Kombinacija za upotrebu prema patentnom zahtjevu 5, naznačena time da je u obliku pogodnom za topičko davanje.
7. Kombinacija za upotrebu prema patentnim zahtjevima 5-6, naznačena time da su ekstrakti formulirani u uljima u prisutnosti površinski aktivnih tvari ili fosfolipida.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2010A001373A IT1401141B1 (it) | 2010-07-26 | 2010-07-26 | Formulazioni contenenti estratti di echinacea angustifolia e di zingiber officinale utili nella riduzione dell'infiammazione e del dolore periferico |
| PCT/EP2011/062421 WO2012013551A1 (en) | 2010-07-26 | 2011-07-20 | Formulations containing extracts of echinacea angustifolia and zingiber officinale which are useful in reducing inflammation and peripheral pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HRP20140583T1 true HRP20140583T1 (hr) | 2014-08-01 |
| HRP20140583T8 HRP20140583T8 (hr) | 2014-10-24 |
Family
ID=43739919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20140583AT HRP20140583T8 (hr) | 2010-07-26 | 2014-06-23 | Formulacije koje sadrže ekstrakte echinacea angustifolia i zingiber officinale koje su korisne za smanjivanje upale i periferne boli |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US9283259B2 (hr) |
| EP (1) | EP2598156B1 (hr) |
| JP (1) | JP5996534B2 (hr) |
| KR (1) | KR101812746B1 (hr) |
| CN (1) | CN103096907B (hr) |
| AR (1) | AR082342A1 (hr) |
| AU (1) | AU2011285025B2 (hr) |
| BR (1) | BR112013001838A2 (hr) |
| CA (1) | CA2806428C (hr) |
| CL (1) | CL2013000241A1 (hr) |
| DK (1) | DK2598156T3 (hr) |
| ES (1) | ES2477548T3 (hr) |
| HR (1) | HRP20140583T8 (hr) |
| IL (1) | IL224388A (hr) |
| IT (1) | IT1401141B1 (hr) |
| MX (1) | MX338951B (hr) |
| PL (1) | PL2598156T3 (hr) |
| PT (1) | PT2598156E (hr) |
| RU (1) | RU2565436C2 (hr) |
| SG (1) | SG187601A1 (hr) |
| SI (1) | SI2598156T1 (hr) |
| WO (1) | WO2012013551A1 (hr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20121317A1 (it) * | 2012-07-27 | 2014-01-28 | Indena Spa | Composizioni per il trattamento della fatica oncologica |
| EP2968108B1 (en) | 2013-03-14 | 2020-01-22 | Mary Kay, Inc. | Cosmetic compositions comprising echinacea purpurea and silybum marianum extracts |
| ITMI20130807A1 (it) * | 2013-05-16 | 2014-11-17 | Indena Spa | Combinazioni di estratti di serenoa repens e di estratti lipofili di zingiber officinalis e di echinacea angustifolia, loro uso e formulazioni che li contengono |
| AU2014373611A1 (en) | 2013-12-24 | 2016-07-14 | Innovative Herbal Products (Aust) Pty Ltd | Treatment of pain |
| SG11201606831PA (en) * | 2014-02-20 | 2016-09-29 | Indena Spa | Compositions containing extracts of curcuma longa and echinacea angustifolia which are useful to reduce peripheral inflammation and pain |
| CN103961482A (zh) * | 2014-04-23 | 2014-08-06 | 湖州康企药业有限公司 | 一种治疗皮炎的天然药物 |
| DE202015006894U1 (de) * | 2015-08-31 | 2015-12-21 | Dr. August Wolff Gmbh & Co. Kg Arzneimittel | Zusammensetzungen enthaltend einen Extrakt aus Echinacea und Linolsäurederivate |
| EP3150214A1 (en) * | 2015-10-01 | 2017-04-05 | INDENA S.p.A. | Compositions containing extracts of curcuma spp and zingiber officinale which are useful to reduce peripheral inflammation and pain |
| ITUB20161030A1 (it) * | 2016-02-24 | 2017-08-24 | Indena Spa | Composizioni utili nella prevenzione e/o nel trattamento dell’infiammazione e del dolore |
| ITUA20161822A1 (it) * | 2016-03-18 | 2017-09-18 | Indena Spa | Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago |
| KR101684218B1 (ko) * | 2016-04-04 | 2016-12-07 | 이경복 | 통증 완화를 위한 에센셜 오일 |
| BR112018074709B1 (pt) * | 2016-05-30 | 2022-01-18 | Symrise Ag | Medicamento compreendendo esclareolido, método não terapêutico para tratamento da hiperpigmentação induzida por luz visível na faixa de 400 nm a 700 nm, e uso cosmético não terapêutico de esclareolido |
| ITUA20164757A1 (it) * | 2016-06-29 | 2017-12-29 | Indena Spa | Composizioni utili nella prevenzione e/o nel trattamento dell’infiammazione e del dolore osteoarticolare e del danno cartilagineo |
| EP3335716A1 (en) * | 2016-12-15 | 2018-06-20 | Indena S.p.A. | Process for the preparation of powder compositions |
| EP3607959A1 (en) * | 2018-08-10 | 2020-02-12 | Raman Mehta | Formulations containing lipophilic extracts of spicy edible plants useful in controlling pain and inflammation |
| US11147835B1 (en) | 2020-08-20 | 2021-10-19 | Frank Kelly Reilly, III | Nutritional supplement |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0464298T3 (da) * | 1990-07-05 | 1995-11-13 | Indena Spa | Echinacea-ekstrakter, fremgangsmåde til fremstilling deraf og formuleringer, der indeholder dem |
| JP3030062B2 (ja) * | 1990-07-26 | 2000-04-10 | インデナ・ソチエタ・ペル・アチオニ | エキナセア抽出物、抽出物の製造方法及びそれらを含む製剤 |
| WO1999021007A1 (en) * | 1997-10-23 | 1999-04-29 | Pharmaprint, Inc. | Pharmaceutical grade echinacea |
| US20010046523A1 (en) * | 2000-02-25 | 2001-11-29 | Thomas Newmark | Ginger-based herbal composition for promoting health and methods of using same |
| US6274177B1 (en) * | 2000-08-26 | 2001-08-14 | National Science Council | Method of preparing an extract potent in anti-inflammation and anti-platelet aggregation from Zingiber officinale and pharmaceutical compositions containing said extract |
| CN1279963C (zh) * | 2001-06-07 | 2006-10-18 | 财团法人制药工业技术发展中心 | 从姜制备含抗发炎、抗血小板凝集或抗菌活性的有效成分的产品及方法和产品的医药组成物 |
| US20030157185A1 (en) * | 2002-02-08 | 2003-08-21 | Lou Paradise | Topical treatment of neuropathy |
| ITMI20021691A1 (it) * | 2002-07-30 | 2004-01-30 | Indena Spa | Estratti di echinacea angustifolia |
| ITMI20032286A1 (it) * | 2003-11-24 | 2005-05-25 | Indena Spa | Composizioni per il trattamento di dermatiti atopiche di stati allergici cutanei e dell'acne |
| JP5303697B2 (ja) * | 2005-10-26 | 2013-10-02 | オリザ油化株式会社 | 抗炎症剤 |
| US7282224B1 (en) * | 2006-06-09 | 2007-10-16 | Guthy-Renker Corporation | Pain relief composition |
| US20080160116A1 (en) * | 2006-12-07 | 2008-07-03 | Herbalscience Singapore Pte. Ltd | Compositions and Methods Comprising Zingiber Species |
| CN101125136B (zh) * | 2006-12-26 | 2010-06-02 | 广东药学院 | 高良姜二苯基庚烷类化合物在镇痛抗炎中的应用及其提取方法 |
| EP2009023A1 (en) * | 2007-06-04 | 2008-12-31 | Rentschler Beteiligungs GmbH | Novel peptides and their use for the treatment of edema |
| US7824986B2 (en) * | 2008-11-05 | 2010-11-02 | Micron Technology, Inc. | Methods of forming a plurality of transistor gates, and methods of forming a plurality of transistor gates having at least two different work functions |
| ITMI20090049A1 (it) * | 2009-01-20 | 2010-07-21 | Indena Spa | Composizioni a base di estratti lipofili di zingiber officinale e di echinacea angustifolia per la prevenzione e il trattamento del riflusso gastro-esofageo e dell'emesi indotta da chemioterapici |
-
2010
- 2010-07-26 IT ITMI2010A001373A patent/IT1401141B1/it active
-
2011
- 2011-07-20 SG SG2013005830A patent/SG187601A1/en unknown
- 2011-07-20 CN CN201180036216.8A patent/CN103096907B/zh not_active Expired - Fee Related
- 2011-07-20 US US13/811,503 patent/US9283259B2/en not_active Expired - Fee Related
- 2011-07-20 WO PCT/EP2011/062421 patent/WO2012013551A1/en active Application Filing
- 2011-07-20 MX MX2013000999A patent/MX338951B/es active IP Right Grant
- 2011-07-20 AU AU2011285025A patent/AU2011285025B2/en not_active Ceased
- 2011-07-20 DK DK11740605.8T patent/DK2598156T3/da active
- 2011-07-20 KR KR1020137001988A patent/KR101812746B1/ko active IP Right Grant
- 2011-07-20 JP JP2013521066A patent/JP5996534B2/ja not_active Expired - Fee Related
- 2011-07-20 ES ES11740605.8T patent/ES2477548T3/es active Active
- 2011-07-20 BR BR112013001838A patent/BR112013001838A2/pt not_active Application Discontinuation
- 2011-07-20 CA CA2806428A patent/CA2806428C/en active Active
- 2011-07-20 SI SI201130196T patent/SI2598156T1/sl unknown
- 2011-07-20 PT PT117406058T patent/PT2598156E/pt unknown
- 2011-07-20 RU RU2013103334/15A patent/RU2565436C2/ru active
- 2011-07-20 EP EP11740605.8A patent/EP2598156B1/en active Active
- 2011-07-20 PL PL11740605T patent/PL2598156T3/pl unknown
- 2011-07-25 AR ARP110102682A patent/AR082342A1/es not_active Application Discontinuation
-
2013
- 2013-01-24 CL CL2013000241A patent/CL2013000241A1/es unknown
- 2013-01-24 IL IL224388A patent/IL224388A/en active IP Right Grant
-
2014
- 2014-06-23 HR HRP20140583AT patent/HRP20140583T8/hr unknown
-
2016
- 2016-02-04 US US15/015,795 patent/US9839663B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20140583T1 (hr) | Formulacije koje sadrže ekstrakte echinacea angustifolia i zingiber officinale koje se koriste za smanjivanje upale i periferne boli | |
| BR112012029653A2 (pt) | formulação tópica para um inibidor jak | |
| CL2013000481A1 (es) | Metodo y para mejorar la eficacia y/o reducir los efectos secundarios de una farmacoterapia administrada de forma suboptima que comprende la administracion de un hexitol sustituido; composicion farmaceutica; combinacion farmaceutica; uso para tratar enfermedades proliferativas. | |
| CO6592098A2 (es) | Formulacion estable de mia/cd-rap | |
| IN2014MN02269A (hr) | ||
| CO6660486A2 (es) | Composición tópica famacéutica o cosmética útil para el tratamiento de enfermedades o condiciones que cursan con un déficit de la maduración de la envoltura córnea | |
| MX2022001736A (es) | Formulaciones y tratamientos topicos. | |
| SA519410993B1 (ar) | النشاط المضاد للبكتيريا لأوليجو سكاريد من جالاكتو وزيليتول في العلاجات الجلدية | |
| WO2014041542A3 (en) | Topical compositions for the treatment of acne | |
| HRP20201630T1 (hr) | Sastavi i postupci za liječenje kožnog t-staničnog limfoma | |
| BR112014004737A2 (pt) | composto de composição de cloridrato de ambroxol e método de preparação do composto | |
| IN2014DN10134A (hr) | ||
| WO2014091146A3 (fr) | Utilisation cosmetique d'un extrait de germe de caroube en tant qu'agent actif amincissant | |
| SI2694065T1 (en) | A composition for treating a disorder of hypoactive sexual desire | |
| Fatima Grace et al. | Formulation and evaluation of polyherbal anti-acne Gel | |
| BRPI0602179A (pt) | composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação | |
| CN104055888A (zh) | 一种清热解毒的保健组合物 | |
| GB201318377D0 (en) | Drug-free compositions and methods for diminishing peripheral inflammation and pain | |
| BR112017019102A2 (pt) | formulação cosmética antioxidante para uso tópico compreendendo uma associação de extratos vegetais, e uso da mesma | |
| MX2019007078A (es) | Procedimiento para la preparacion de composiciones en polvo. | |
| ES1263215U (es) | Composición capilar | |
| ES2269627T3 (es) | Asociacion de arnica, rusco y mentol. | |
| BR112017022026A2 (pt) | composições para formulação cosmética de hidratação prolongada compreendendo manteiga de ucuuba com elevada concentração de ácido mirístico, bem como uso da dita formulação para preparação de um produto cosmético com alto poder hidrante e kit | |
| UA116823C2 (uk) | Фітокомпозиція для лікування або профілактики інфекційно-запальних захворювань із загальнозміцнюючою та оздоровчою дією | |
| RS52905B (en) | COMPOSITION AND PROCEDURE OF OBTAINING PHYTOPREPARATS BASED ON MINERAL WAD AND MEDICINAL HERBS FOR APPLICATION IN DIFFERENT SKIN DISEASES |